论文部分内容阅读
目的讨论高血压并发冠心病患者救治中联合用药氨氯地平以及阿托伐他汀钙片的意义。方法此次以90例于2014年02月至2016年04月因高血压并发冠心病进入我院的患者作治疗对象,以使用不同药品为依据,对90例患者分组。常规组41例用药氨氯地平,治疗组49例则联合用药氨氯地平以及阿托伐他汀钙片,对两组病例用药效果、病情改善质量客观对比。结果用药两个月后,常规组41例病例的有效率是78.05%(32/41),治疗组49例是95.92%(47/49),(P<0.05)。此外,两组血压指数、血脂指数相对比,(P<0.05)。结论临床救治高血压并发冠心病患者时,选择用药氨氯地平阿托伐他汀钙片疗效显著。
Objective To discuss the significance of combined amlodipine and atorvastatin calcium in the treatment of patients with hypertension and coronary heart disease. Methods Totally 90 patients who entered our hospital from February 2014 to April 2016 due to hypertension complicated with coronary heart disease were enrolled in this study. Based on different drugs, 90 patients were divided into groups. In the conventional group, 41 cases were treated with amlodipine, while 49 cases in the treatment group were treated with amlodipine and atorvastatin calcium tablets. The therapeutic effect and the quality of the disease were objectively compared between the two groups. Results After two months of treatment, the effective rate of the routine group was 78.05% (32/41) and that of the treatment group was 95.92% (47/49) (P <0.05). In addition, the two groups of blood pressure index, lipid index relative (P <0.05). Conclusion Amlodipine atorvastatin is effective in treating hypertension with coronary heart disease.